HDFC Pharma and Healthcare Fund - Direct - Growth

Equity Scheme by HDFC Asset Management Company Limited

1Y Returns (CAGR)
27.15%
Expense Ratio
0.93%

as of 01/03/2026

AUM
₹765.67 Cr

Qtr End: Jun 26

NAV
₹22.436

as of 02/09/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M11.39%53.98%10.49%
6M24.29%54.49%13.68%
1Y27.15%27.15%13.18%
3YN/AN/AN/A
5YN/AN/AN/A
Scheme Details
Launch Date
14/09/2023
Fund Age
3 years
Minimum Investment
₹100
Fund House
HDFC Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions